is seeking bids for Belgium EMA receives application for marketing authorisation for Ronapreve casirivimab imdevimab for treatment and prevention of COVID-19 in Belgium. Interested suppliers and service providers may participate until 18 Oct 2021.
Start Your Business Journey. Register now for 3 days Free Sample Tenders & AI Website Demo.